These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37321375)

  • 1. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
    Kang DD; Li H; Dong Y
    Adv Drug Deliv Rev; 2023 Aug; 199():114961. PubMed ID: 37321375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA vaccines: the most recent clinical applications of synthetic mRNA.
    Kwon S; Kwon M; Im S; Lee K; Lee H
    Arch Pharm Res; 2022 Apr; 45(4):245-262. PubMed ID: 35426547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVT-mRNA reprogramming of myeloid cells for cancer immunotherapy.
    Jolly KJ; Zhang F
    Adv Pharmacol; 2024; 100():247-288. PubMed ID: 39034054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA-based therapies: Preclinical and clinical applications.
    Qureischi M; Mohr J; Arellano-Viera E; Knudsen SE; Vohidov F; Garitano-Trojaola A
    Int Rev Cell Mol Biol; 2022; 372():1-54. PubMed ID: 36064262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules.
    Zhang J; Liu Y; Li C; Xiao Q; Zhang D; Chen Y; Rosenecker J; Ding X; Guan S
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.
    Guan S; Rosenecker J
    Gene Ther; 2017 Mar; 24(3):133-143. PubMed ID: 28094775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo.
    Mamaghani S; Penna RR; Frei J; Wyss C; Mellett M; Look T; Weiss T; Guenova E; Kündig TM; Lauchli S; Pascolo S
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology.
    Ye Z; Harmon J; Ni W; Li Y; Wich D; Xu Q
    ACS Nano; 2023 Aug; 17(16):15231-15253. PubMed ID: 37535899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of
    Mu X; Hur S
    Acc Chem Res; 2021 Nov; 54(21):4012-4023. PubMed ID: 34677064
    [No Abstract]   [Full Text] [Related]  

  • 10. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
    Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
    RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity.
    Warzak DA; Pike WA; Luttgeharm KD
    SLAS Technol; 2023 Oct; 28(5):369-374. PubMed ID: 37833008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica Particle as an RNA Adsorbent for Facile Purification of In Vitro-Transcribed RNA.
    Cho E; Namgung J; Lee JS; Jang J; Jun BH; Kim DE
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE mRNA (Additional Chimeric Element incorporated IVT mRNA) for Enhancing Protein Expression by Modulating Immunogenicity.
    Son S; Park M; Kim J; Lee K
    Adv Sci (Weinh); 2024 May; 11(18):e2307541. PubMed ID: 38447169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
    Deng Z; Tian Y; Song J; An G; Yang P
    Front Immunol; 2022; 13():887125. PubMed ID: 35720301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited].
    Jawalagatti V; Kirthika P; Lee JH
    Front Immunol; 2022; 13():884862. PubMed ID: 35592330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
    Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
    Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape.
    Miliotou AN; Georgiou-Siafis SK; Ntenti C; Pappas IS; Papadopoulou LC
    Curr Issues Mol Biol; 2023 Nov; 45(11):9181-9214. PubMed ID: 37998753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity.
    Loomis KH; Lindsay KE; Zurla C; Bhosle SM; Vanover DA; Blanchard EL; Kirschman JL; Bellamkonda RV; Santangelo PJ
    Bioconjug Chem; 2018 Sep; 29(9):3072-3083. PubMed ID: 30067354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 mRNA vaccines: Platforms and current developments.
    Szabó GT; Mahiny AJ; Vlatkovic I
    Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.